Annual Accounts Receivable
$39.29 M
-$994.00 K-2.47%
December 31, 2023
Summary
- As of February 8, 2025, AKBA annual accounts receivable is $39.29 million, with the most recent change of -$994.00 thousand (-2.47%) on December 31, 2023.
- During the last 3 years, AKBA annual accounts receivable has risen by +$12.44 million (+46.32%).
- AKBA annual accounts receivable is now -23.83% below its all-time high of $51.58 million, reached on December 31, 2021.
Performance
AKBA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$32.17 M
+$2.40 M+8.08%
September 30, 2024
Summary
- As of February 8, 2025, AKBA quarterly accounts receivable is $32.17 million, with the most recent change of +$2.40 million (+8.08%) on September 30, 2024.
- Over the past year, AKBA quarterly accounts receivable has increased by +$2.40 million (+8.08%).
- AKBA quarterly accounts receivable is now -69.32% below its all-time high of $104.87 million, reached on March 31, 2020.
Performance
AKBA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AKBA Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.5% | +8.1% |
| 3 y3 years | +46.3% | -37.6% |
| 5 y5 years | +135.8% | -37.6% |
AKBA Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.8% | at low | -60.7% | +80.9% |
| 5 y | 5-year | -23.8% | +46.3% | -69.3% | +80.9% |
| alltime | all time | -23.8% | >+9999.0% | -69.3% | >+9999.0% |
Akebia Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $32.17 M(+8.1%) |
| Jun 2024 | - | $29.77 M(+11.8%) |
| Mar 2024 | - | $26.62 M(-32.2%) |
| Dec 2023 | $39.29 M(-2.5%) | $39.29 M(+73.9%) |
| Sep 2023 | - | $22.59 M(+15.4%) |
| Jun 2023 | - | $19.57 M(+10.1%) |
| Mar 2023 | - | $17.78 M(-55.9%) |
| Dec 2022 | $40.28 M(-21.9%) | $40.28 M(+74.4%) |
| Sep 2022 | - | $23.09 M(-71.8%) |
| Jun 2022 | - | $81.87 M(+26.8%) |
| Mar 2022 | - | $64.58 M(+25.2%) |
| Dec 2021 | $51.58 M(+92.1%) | $51.58 M(+3.8%) |
| Sep 2021 | - | $49.69 M(+42.0%) |
| Jun 2021 | - | $35.01 M(-0.6%) |
| Mar 2021 | - | $35.23 M(+31.2%) |
| Dec 2020 | $26.85 M | $26.85 M(+9.8%) |
| Sep 2020 | - | $24.47 M(-37.5%) |
| Jun 2020 | - | $39.12 M(-62.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $104.87 M(+169.8%) |
| Dec 2019 | $38.86 M(+133.2%) | $38.86 M(+31.1%) |
| Sep 2019 | - | $29.65 M(+2.7%) |
| Jun 2019 | - | $28.89 M(-40.4%) |
| Mar 2019 | - | $48.44 M(+190.6%) |
| Dec 2018 | $16.67 M(-51.3%) | $16.67 M(+2322.4%) |
| Sep 2018 | - | $688.00 K(+421.2%) |
| Jun 2018 | - | $132.00 K(-99.6%) |
| Mar 2018 | - | $35.85 M(+4.8%) |
| Dec 2017 | $34.22 M(+1.2%) | $34.22 M(+1.2%) |
| Dec 2016 | $33.82 M(>+9900.0%) | $33.82 M(>+9900.0%) |
| Sep 2015 | - | $14.00 K(-70.8%) |
| Jun 2015 | - | $48.00 K(-35.1%) |
| Mar 2015 | - | $74.00 K(+29.8%) |
| Sep 2014 | - | $57.00 K(-50.0%) |
| Jun 2014 | - | $114.00 K(-4.5%) |
| Mar 2014 | - | $119.40 K(-11.6%) |
| Dec 2013 | $135.00 K(+57.7%) | $135.00 K |
| Dec 2012 | $85.60 K | - |
FAQ
- What is Akebia Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Akebia Therapeutics?
- What is Akebia Therapeutics annual accounts receivable year-on-year change?
- What is Akebia Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly accounts receivable year-on-year change?
What is Akebia Therapeutics annual accounts receivable?
The current annual accounts receivable of AKBA is $39.29 M
What is the all time high annual accounts receivable for Akebia Therapeutics?
Akebia Therapeutics all-time high annual accounts receivable is $51.58 M
What is Akebia Therapeutics annual accounts receivable year-on-year change?
Over the past year, AKBA annual accounts receivable has changed by -$994.00 K (-2.47%)
What is Akebia Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of AKBA is $32.17 M
What is the all time high quarterly accounts receivable for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly accounts receivable is $104.87 M
What is Akebia Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, AKBA quarterly accounts receivable has changed by +$2.40 M (+8.08%)